Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Nafcillin | hsa00030 | Pentose phosphate pathway | 5.07E-03 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Nafcillin | hsa00052 | Galactose metabolism | 5.00E-02 | 1 | P35557 | GCK | More | | Nafcillin | hsa00220 | Arginine biosynthesis | 1.54E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Nafcillin | hsa00310 | Lysine degradation | 3.77E-02 | 2 | Q8NEZ4, Q13029 | MLL3, PRDM2 | More | | Nafcillin | hsa00500 | Starch and sucrose metabolism | 3.86E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Nafcillin | hsa00510 | N-Glycan biosynthesis | 3.15E-02 | 2 | P15907, Q9NR34 | ST6GAL1, MAN1C1 | More | | Nafcillin | hsa00520 | Amino sugar and nucleotide sugar metabolism | 1.57E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Nafcillin | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 1.27E-02 | 1 | P35557 | GCK | More | | Nafcillin | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 7.02E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Nafcillin | hsa00630 | Glyoxylate and dicarboxylate metabolism | 5.34E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Nafcillin | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Nafcillin | hsa00983 | Drug metabolism - other enzymes | 3.20E-02 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Nafcillin | hsa01522 | Endocrine resistance | 4.51E-02 | 2 | P04637, P42773 | TP53, CDKN2C | More | | Nafcillin | hsa03040 | Spliceosome | 4.19E-02 | 5 | Q14562, O60508, P08579, Q01130, O43447 | DHX8, CDC40, SNRPB2, SFRS2, PPIH | More | | Nafcillin | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Nafcillin | hsa03060 | Protein export | 1.90E-02 | 2 | Q15070, O76094 | OXA1L, SRP72 | More | | Nafcillin | hsa04015 | Rap1 signaling pathway | 2.26E-02 | 3 | P25116, Q8TEU7, P08514 | F2R, RAPGEF6, ITGA2B | More | | Nafcillin | hsa04022 | cGMP-PKG signaling pathway | 1.05E-02 | 3 | P24844, Q8WYR1, Q15746 | MYL9, PIK3R5, MYLK | More | | Nafcillin | hsa04024 | cAMP signaling pathway | 1.40E-02 | 3 | P48058, P25116, P24844 | GRIA4, F2R, MYL9 | More | | Nafcillin | hsa04060 | Cytokine-cytokine receptor interaction | 5.39E-03 | 10 | P27930, P08476, Q13651, Q9HBE5, Q9UBD3, P47992, P01375, P09341, P18510, Q93038 | IL1R2, INHBA, IL10RA, IL21R, XCL2, XCL1, TNF, CXCL1, IL1RN, TNFRSF25 | More | | Nafcillin | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 3.36E-04 | 9 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784, P01375 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Nafcillin | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Nafcillin | hsa04064 | NF-kappa B signaling pathway | 3.54E-06 | 15 | P10415, O00463, P14778, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q13315, P24522, P09341, P19875, Q06643 | BCL2, TRAF5, IL1R1, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, ATM, GADD45A, CXCL1, CXCL2, LTB | More | | Nafcillin | hsa04071 | Sphingolipid signaling pathway | 4.56E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Nafcillin | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Nafcillin | hsa04110 | Cell cycle | 1.29E-02 | 4 | P30260, P04637, P49918, P42773 | CDC27, TP53, CDKN1C, CDKN2C | More | | Nafcillin | hsa04114 | Oocyte meiosis | 1.31E-02 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Nafcillin | hsa04140 | Autophagy - animal | 4.55E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Nafcillin | hsa04144 | Endocytosis | 4.10E-02 | 3 | O75351, P62491, Q14161 | VPS4B, RAB11A, GIT2 | More | | Nafcillin | hsa04145 | Phagosome | 3.69E-02 | 7 | O75015, Q15080, P05164, P78380, O60603, P35443, P13765 | FCGR3B, NCF4, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Nafcillin | hsa04151 | PI3K-Akt signaling pathway | 4.57E-02 | 3 | P04637, Q96BR1, P56279 | TP53, SGK3, TCL1A | More | | Nafcillin | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Nafcillin | hsa04270 | Vascular smooth muscle contraction | 4.65E-02 | 2 | Q15746, P24844 | MYLK, MYL9 | More | | Nafcillin | hsa04340 | Hedgehog signaling pathway | 3.46E-02 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Nafcillin | hsa04370 | VEGF signaling pathway | 5.06E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Nafcillin | hsa04510 | Focal adhesion | 3.36E-02 | 3 | P08514, Q15746, P24844 | ITGA2B, MYLK, MYL9 | More | | Nafcillin | hsa04512 | ECM-receptor interaction | 2.44E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Nafcillin | hsa04514 | Cell adhesion molecules | 4.65E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Nafcillin | hsa04530 | Tight junction | 7.42E-04 | 4 | Q8TEU7, O00501, Q14247, P24844 | RAPGEF6, CLDN5, CTTN, MYL9 | More | | Nafcillin | hsa04610 | Complement and coagulation cascades | 2.94E-02 | 2 | P25116, P10909 | F2R, CLU | More | | Nafcillin | hsa04611 | Platelet activation | 1.59E-05 | 5 | P25116, P08514, Q15746, Q8WYR1, P07359 | F2R, ITGA2B, MYLK, PIK3R5, GP1BA | More | | Nafcillin | hsa04612 | Antigen processing and presentation | 4.81E-06 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Nafcillin | hsa04613 | Neutrophil extracellular trap formation | 3.61E-02 | 13 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Nafcillin | hsa04621 | NOD-like receptor signaling pathway | 2.62E-02 | 11 | Q16539, Q14643, P10599, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P09341, P12838 | MAPK14, ITPR1, TXN, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CXCL1, DEFA4 | More | | Nafcillin | hsa04640 | Hematopoietic cell lineage | 1.53E-05 | 12 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD7, HLA-DOB, TNF | More | | Nafcillin | hsa04650 | Natural killer cell mediated cytotoxicity | 5.02E-09 | 12 | P19174, P01375, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, P26715 | PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P49863 | GZMK | Granzyme K | P01375 | TNF | Tumor necrosis factor | -0.8 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P13612 | ITGA4 | Integrin alpha-4 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.732 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | P49863 | GZMK | Granzyme K | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.899 | P08311 | CTSG | Cathepsin G | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.92 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P13612 | ITGA4 | Integrin alpha-4 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.768 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.852 | P13612 | ITGA4 | Integrin alpha-4 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.814 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | P49863 | GZMK | Granzyme K | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.809 | P08311 | CTSG | Cathepsin G | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.812 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.922 | P13612 | ITGA4 | Integrin alpha-4 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.818 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | P49863 | GZMK | Granzyme K | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.96 | P08311 | CTSG | Cathepsin G | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.875 | P13612 | ITGA4 | Integrin alpha-4 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.729 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.778 | P49863 | GZMK | Granzyme K | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.775 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.943 | P13612 | ITGA4 | Integrin alpha-4 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.772 | P49863 | GZMK | Granzyme K | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.891 | P08311 | CTSG | Cathepsin G | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.867 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.943 | P13612 | ITGA4 | Integrin alpha-4 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.772 | P49863 | GZMK | Granzyme K | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.891 | P08311 | CTSG | Cathepsin G | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.867 |
| Nafcillin | hsa04657 | IL-17 signaling pathway | 9.21E-05 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Nafcillin | hsa04658 | Th1 and Th2 cell differentiation | 7.34E-15 | 13 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P49863 | GZMK | Granzyme K | Q04759 | PRKCQ | Protein kinase C theta type | 0.874 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P13612 | ITGA4 | Integrin alpha-4 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.729 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P49863 | GZMK | Granzyme K | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.745 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P13612 | ITGA4 | Integrin alpha-4 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.768 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P13612 | ITGA4 | Integrin alpha-4 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.85 | P49863 | GZMK | Granzyme K | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.786 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P49863 | GZMK | Granzyme K | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.756 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P13612 | ITGA4 | Integrin alpha-4 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.732 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.861 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.904 | P49863 | GZMK | Granzyme K | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.848 | P08311 | CTSG | Cathepsin G | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.81 | P14780 | MMP9 | Matrix metalloproteinase-9 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.747 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | P13612 | ITGA4 | Integrin alpha-4 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.764 | P49863 | GZMK | Granzyme K | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.768 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.808 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | P13612 | ITGA4 | Integrin alpha-4 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.822 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P49863 | GZMK | Granzyme K | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.918 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P49863 | GZMK | Granzyme K | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.882 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P13612 | ITGA4 | Integrin alpha-4 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.78 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.884 | P49863 | GZMK | Granzyme K | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.704 |
| Nafcillin | hsa04659 | Th17 cell differentiation | 1.06E-08 | 13 | Q04759, Q16539, P19174, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, MAPK14, PLCG1, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Nafcillin | hsa04660 | T cell receptor signaling pathway | 3.67E-13 | 15 | P01375, Q9UDY8, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P49863 | GZMK | Granzyme K | P01375 | TNF | Tumor necrosis factor | -0.8 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.767 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.721 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P49863 | GZMK | Granzyme K | Q04759 | PRKCQ | Protein kinase C theta type | 0.874 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P14780 | MMP9 | Matrix metalloproteinase-9 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.792 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.925 | P13612 | ITGA4 | Integrin alpha-4 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.834 | P49863 | GZMK | Granzyme K | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.872 | P08311 | CTSG | Cathepsin G | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.705 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.855 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 1 | P13612 | ITGA4 | Integrin alpha-4 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.774 | P49863 | GZMK | Granzyme K | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.952 | P08311 | CTSG | Cathepsin G | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.866 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P13612 | ITGA4 | Integrin alpha-4 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.729 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P49863 | GZMK | Granzyme K | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.745 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P13612 | ITGA4 | Integrin alpha-4 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.768 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P13612 | ITGA4 | Integrin alpha-4 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.85 | P49863 | GZMK | Granzyme K | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.786 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.742 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | P13612 | ITGA4 | Integrin alpha-4 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P49863 | GZMK | Granzyme K | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.784 | P08311 | CTSG | Cathepsin G | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.826 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.793 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.811 | P13612 | ITGA4 | Integrin alpha-4 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.83 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | P49863 | GZMK | Granzyme K | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.793 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P13612 | ITGA4 | Integrin alpha-4 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.732 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P49863 | GZMK | Granzyme K | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.756 | P14780 | MMP9 | Matrix metalloproteinase-9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.75 | P49863 | GZMK | Granzyme K | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.716 |
| Nafcillin | hsa04662 | B cell receptor signaling pathway | 1.49E-03 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Nafcillin | hsa04664 | Fc epsilon RI signaling pathway | 2.32E-02 | 3 | P42338, P07948, P09917 | PIK3CB, LYN, ALOX5 | More | | Nafcillin | hsa04668 | TNF signaling pathway | 3.19E-02 | 7 | P01375, O00463, Q16539, P09341, P20749, Q13077, P14780 | TNF, TRAF5, MAPK14, CXCL1, BCL3, TRAF1, MMP9 | More | | Nafcillin | hsa04720 | Long-term potentiation | 4.48E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Nafcillin | hsa04721 | Synaptic vesicle cycle | 3.77E-02 | 1 | P43003 | SLC1A3 | More | | Nafcillin | hsa04724 | Glutamatergic synapse | 4.83E-04 | 6 | P48058, O15399, P63218, P50151, P15104, Q9NSB8 | GRIA4, GRIN2D, GNG5, GNG10, GLUL, HOMER2 | More | | Nafcillin | hsa04725 | Cholinergic synapse | 4.10E-02 | 3 | P63218, P50151, P42338 | GNG5, GNG10, PIK3CB | More | | Nafcillin | hsa04727 | GABAergic synapse | 1.63E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Nafcillin | hsa04750 | Inflammatory mediator regulation of TRP channels | 9.48E-04 | 8 | P14778, P22694, Q16539, P19174, P42338, Q14643, P24723, Q04759 | IL1R1, PRKACB, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ | More | | Nafcillin | hsa04810 | Regulation of actin cytoskeleton | 1.38E-03 | 4 | P24844, Q15746, P08514, P25116 | MYL9, MYLK, ITGA2B, F2R | More | | Nafcillin | hsa04914 | Progesterone-mediated oocyte maturation | 1.83E-02 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | | Nafcillin | hsa04921 | Oxytocin signaling pathway | 6.37E-03 | 3 | Q15746, P24844, Q8WYR1 | MYLK, MYL9, PIK3R5 | More | | Nafcillin | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Nafcillin | hsa04926 | Relaxin signaling pathway | 5.70E-03 | 5 | P42338, P63218, P50151, P49767, P49407 | PIK3CB, GNG5, GNG10, VEGFC, ARRB1 | More | | Nafcillin | hsa04929 | GnRH secretion | 4.62E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Nafcillin | hsa04934 | Cushing syndrome | 4.06E-02 | 5 | Q14643, P22694, P49841, Q9UJU2, O00170 | ITPR1, PRKACB, GSK3B, LEF1, AIP | More | | Nafcillin | hsa04950 | Maturity onset diabetes of the young | 1.27E-02 | 1 | P35557 | GCK | More | | Nafcillin | hsa04962 | Vasopressin-regulated water reabsorption | 1.80E-02 | 2 | P62491, P46459 | RAB11A, NSF | More | | Nafcillin | hsa04964 | Proximal tubule bicarbonate reclamation | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Nafcillin | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Nafcillin | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Nafcillin | hsa05130 | Pathogenic Escherichia coli infection | 2.51E-02 | 3 | Q14247, O00501, P25116 | CTTN, CLDN5, F2R | More | | Nafcillin | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Nafcillin | hsa05135 | Yersinia infection | 4.26E-02 | 6 | P13612, P06239, Q16539, P01375, P49841, P01732 | ITGA4, LCK, MAPK14, TNF, GSK3B, CD8A | More | | Nafcillin | hsa05140 | Leishmaniasis | 1.79E-03 | 7 | P13612, O75015, P13765, O60603, P01375, Q16539, Q15080 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MAPK14, NCF4 | More | | Nafcillin | hsa05144 | Malaria | 1.14E-02 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Nafcillin | hsa05146 | Amoebiasis | 1.69E-08 | 12 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Nafcillin | hsa05169 | Epstein-Barr virus infection | 3.72E-02 | 6 | Q13547, P42338, P07948, Q13761, O75293, P07766 | HDAC1, PIK3CB, LYN, RUNX3, GADD45B, CD3E | More | | Nafcillin | hsa05202 | Transcriptional misregulation in cancer | 2.87E-05 | 14 | Q13315, P14780, P27930, Q15744, Q16548, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P41182, P12980, P24522 | ATM, MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13315 | ATM | Serine-protein kinase ATM | 0.752 | P08311 | CTSG | Cathepsin G | Q13315 | ATM | Serine-protein kinase ATM | -0.709 | P14780 | MMP9 | Matrix metalloproteinase-9 | P14780 | MMP9 | Matrix metalloproteinase-9 | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.855 | P08311 | CTSG | Cathepsin G | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.79 | P14780 | MMP9 | Matrix metalloproteinase-9 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.851 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | P08311 | CTSG | Cathepsin G | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.726 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.7 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.833 | P08311 | CTSG | Cathepsin G | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.909 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.921 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.877 | P08311 | CTSG | Cathepsin G | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.79 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.83 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.76 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.76 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P05164 | MPO | Myeloperoxidase | -0.811 | P08311 | CTSG | Cathepsin G | P05164 | MPO | Myeloperoxidase | 0.956 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.858 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P12838 | DEFA4 | Neutrophil defensin 4 | -0.86 | P08311 | CTSG | Cathepsin G | P12838 | DEFA4 | Neutrophil defensin 4 | 0.817 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P08246 | ELA2 | Neutrophil elastase | -0.782 | P08311 | CTSG | Cathepsin G | P08246 | ELA2 | Neutrophil elastase | 0.792 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.9 | P08311 | CTSG | Cathepsin G | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.853 | P14780 | MMP9 | Matrix metalloproteinase-9 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.812 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12980 | LYL1 | Protein lyl-1 | 0.716 | P14780 | MMP9 | Matrix metalloproteinase-9 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.765 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.75 | P08311 | CTSG | Cathepsin G | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.799 |
| Nafcillin | hsa05217 | Basal cell carcinoma | 3.39E-02 | 4 | Q13635, P49841, Q9UJU2, P24522 | PTCH1, GSK3B, LEF1, GADD45A | More | | Nafcillin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 6.30E-05 | 9 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, Q04759, Q16539 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PRKCQ, MAPK14 | More | | Nafcillin | hsa05310 | Asthma | 1.17E-05 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Nafcillin | hsa05321 | Inflammatory bowel disease | 1.06E-10 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Nafcillin | hsa05322 | Systemic lupus erythematosus | 3.90E-02 | 6 | P08246, P08311, P01375, P13765, Q16778, P12814 | ELA2, CTSG, TNF, HLA-DOB, HIST2H2BE, ACTN1 | More | | Nafcillin | hsa05332 | Graft-versus-host disease | 1.91E-05 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | |